carbon monoxide has been researched along with Vascular Diseases in 34 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ventilatory function and carbon monoxide transfer factor were studied in nine adult patients with post-tricuspid intracardiac defects and the Eisenmenger syndrome." | 3.66 | Ventilatory function in the Eisenmenger syndrome. ( Gibson, GJ; Hunter, D; MacArthur, CG, 1979) |
| "Carbon monoxide (CO) is a gaseous molecule produced from heme by heme oxygenase (HO)." | 2.48 | Regulation of ROS production and vascular function by carbon monoxide. ( Choi, YK; Kim, YM; Kwon, YG; Por, ED, 2012) |
| "Carbon monoxide (CO) is a colorless, odorless gas with a reputation for being an anthropogenic poison; there is extensive documentation of the modes of human exposure, toxicokinetics, and health effects." | 2.45 | Carbon monoxide in biology and microbiology: surprising roles for the "Detroit perfume". ( Davidge, KS; Mann, BE; Motterlini, R; Poole, RK; Wilson, JL, 2009) |
| "Carbon monoxide (CO) is an endogenously generated gas that may play an important physiological role in the regulation of vascular tone." | 2.40 | Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. ( Wang, R, 1998) |
| "Carbon monoxide (CO) is an endogenously generated gas that may play an important physiological role in the circulation." | 2.40 | Carbon monoxide and vascular cell function (review). ( Durante, W; Schafer, AI, 1998) |
| "Pulmonary emphysema combined with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) occurs more often in smokers but also in never-smokers." | 1.48 | Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy? ( Baba, T; Ikeda, S; Iso, S; Iwasawa, T; Kitamura, H; Kuwano, K; Ogura, T; Okudela, K; Sekine, A; Takemura, T; Yamakawa, H; Yamanaka, Y, 2018) |
| "Ozone was a predictor of C-reactive protein and ICAM-1." | 1.38 | Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. ( Baccarelli, A; Bind, MA; Schwartz, J; Suh, H; Tarantini, L; Vokonas, P; Zanobetti, A, 2012) |
| "Treatment with nifedipine did not significantly change any of the pulmonary function values, except for the carbon monoxide diffusing capacity (DLCO)." | 1.28 | Diffusing capacity of the lung and nifedipine in systemic sclerosis. ( Georgiakodis, F; Kyriakidis, M; Papazoglou, S; Sfikakis, P; Sfikakis, PP; Toutouzas, P; Vergos, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (17.65) | 18.7374 |
| 1990's | 4 (11.76) | 18.2507 |
| 2000's | 9 (26.47) | 29.6817 |
| 2010's | 11 (32.35) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Favoino, E | 1 |
| Catacchio, G | 1 |
| Mininni, A | 1 |
| Ruscitti, P | 1 |
| Riccieri, V | 1 |
| Liakouli, V | 1 |
| Corrado, A | 1 |
| Navarini, L | 1 |
| Ciccia, F | 1 |
| Cipriani, P | 1 |
| Cantatore, FP | 1 |
| Valesini, G | 1 |
| Giacomelli, R | 1 |
| Perosa, F | 1 |
| Ibrahim, NH | 1 |
| Fawzy, IM | 1 |
| Gouda, TM | 1 |
| El Sayed, RAH | 1 |
| Morsi, MH | 1 |
| Sabry, ASM | 1 |
| Hashaad, NI | 1 |
| Hemnes, AR | 1 |
| Leopold, JA | 1 |
| Radeva, MK | 1 |
| Beck, GJ | 1 |
| Abidov, A | 1 |
| Aldred, MA | 1 |
| Barnard, J | 1 |
| Rosenzweig, EB | 1 |
| Borlaug, BA | 1 |
| Chung, WK | 1 |
| Comhair, SAA | 1 |
| Desai, AA | 1 |
| Dubrock, HM | 1 |
| Erzurum, SC | 1 |
| Finet, JE | 1 |
| Frantz, RP | 1 |
| Garcia, JGN | 1 |
| Geraci, MW | 1 |
| Gray, MP | 1 |
| Grunig, G | 1 |
| Hassoun, PM | 1 |
| Highland, KB | 1 |
| Hill, NS | 1 |
| Hu, B | 1 |
| Kwon, DH | 1 |
| Jacob, MS | 1 |
| Jellis, CL | 1 |
| Larive, AB | 1 |
| Lempel, JK | 1 |
| Maron, BA | 1 |
| Mathai, SC | 1 |
| McCarthy, K | 1 |
| Mehra, R | 1 |
| Nawabit, R | 1 |
| Newman, JH | 1 |
| Olman, MA | 1 |
| Park, MM | 1 |
| Ramos, JA | 1 |
| Renapurkar, RD | 1 |
| Rischard, FP | 1 |
| Sherer, SG | 1 |
| Tang, WHW | 1 |
| Thomas, JD | 1 |
| Vanderpool, RR | 1 |
| Waxman, AB | 1 |
| Wilcox, JD | 1 |
| Yuan, JX | 1 |
| Horn, EM | 1 |
| Wajda, A | 1 |
| Walczyk, M | 1 |
| Dudek, E | 1 |
| Stypińska, B | 1 |
| Lewandowska, A | 1 |
| Romanowska-Próchnicka, K | 1 |
| Chojnowski, M | 1 |
| Olesińska, M | 1 |
| Paradowska-Gorycka, A | 1 |
| Gomperts, E | 1 |
| Belcher, JD | 1 |
| Otterbein, LE | 1 |
| Coates, TD | 1 |
| Wood, J | 1 |
| Skolnick, BE | 1 |
| Levy, H | 1 |
| Vercellotti, GM | 1 |
| Yamakawa, H | 1 |
| Takemura, T | 1 |
| Iwasawa, T | 1 |
| Yamanaka, Y | 1 |
| Ikeda, S | 1 |
| Sekine, A | 1 |
| Kitamura, H | 1 |
| Baba, T | 1 |
| Iso, S | 1 |
| Okudela, K | 1 |
| Kuwano, K | 1 |
| Ogura, T | 1 |
| Abdulle, AE | 1 |
| van Goor, H | 1 |
| Mulder, DJ | 1 |
| Xu, J | 1 |
| Yang, M | 1 |
| Kosterin, P | 1 |
| Salzberg, BM | 1 |
| Milovanova, TN | 1 |
| Bhopale, VM | 1 |
| Thom, SR | 2 |
| Gong, T | 1 |
| Hong, ZY | 1 |
| Chen, CH | 1 |
| Tsai, CY | 1 |
| Liao, LD | 1 |
| Kong, KV | 1 |
| Hegewald, MJ | 1 |
| Baldassarre, D | 1 |
| Castelnuovo, S | 1 |
| Frigerio, B | 1 |
| Amato, M | 1 |
| Werba, JP | 1 |
| De Jong, A | 1 |
| Ravani, AL | 1 |
| Tremoli, E | 1 |
| Sirtori, CR | 1 |
| Abraham, NG | 1 |
| Cao, J | 1 |
| Sacerdoti, D | 1 |
| Li, X | 1 |
| Drummond, G | 1 |
| Davidge, KS | 1 |
| Motterlini, R | 1 |
| Mann, BE | 1 |
| Wilson, JL | 1 |
| Poole, RK | 1 |
| Breimer, LH | 1 |
| Mikhailidis, DP | 1 |
| Schmidt, R | 2 |
| Barbagallo, I | 1 |
| Marrazzo, G | 1 |
| Frigiola, A | 1 |
| Zappala, A | 1 |
| Li Volti, G | 1 |
| Bind, MA | 1 |
| Baccarelli, A | 1 |
| Zanobetti, A | 1 |
| Tarantini, L | 1 |
| Suh, H | 1 |
| Vokonas, P | 1 |
| Schwartz, J | 1 |
| Huang, W | 1 |
| Zhu, T | 1 |
| Pan, X | 1 |
| Hu, M | 1 |
| Lu, SE | 1 |
| Lin, Y | 1 |
| Wang, T | 1 |
| Zhang, Y | 1 |
| Tang, X | 2 |
| Choi, YK | 1 |
| Por, ED | 1 |
| Kwon, YG | 1 |
| Kim, YM | 1 |
| FROMENT, R | 1 |
| FRAISSE, H | 1 |
| FOURIER, P | 1 |
| Qi, J | 1 |
| Du, J | 1 |
| Li, J | 1 |
| Wei, B | 1 |
| Tang, C | 1 |
| Ryter, SW | 2 |
| Morse, D | 1 |
| Choi, AM | 2 |
| Hoetzel, A | 1 |
| Dolinay, T | 1 |
| Kaczorowski, DJ | 1 |
| Zuckerbraun, BS | 1 |
| Chung, HT | 1 |
| Pae, HO | 1 |
| Cha, YN | 1 |
| Wang, R | 1 |
| Durante, W | 1 |
| Schafer, AI | 1 |
| Ohnishi, ST | 1 |
| Fisher, D | 1 |
| Xu, YA | 1 |
| Ischiropoulos, H | 1 |
| MacArthur, CG | 1 |
| Hunter, D | 1 |
| Gibson, GJ | 1 |
| Sfikakis, PP | 1 |
| Kyriakidis, M | 1 |
| Vergos, C | 1 |
| Papazoglou, S | 1 |
| Georgiakodis, F | 1 |
| Toutouzas, P | 1 |
| Sfikakis, P | 1 |
| Lindquist, VA | 1 |
| Astrup, P | 1 |
| Birnstingl, MA | 1 |
| Brinson, K | 1 |
| Chakrabarti, BK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS)[NCT02980887] | 1,195 participants (Actual) | Observational | 2016-11-30 | Active, not recruiting | |||
| Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers[NCT02469428] | 14 participants (Actual) | Interventional | 2013-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for carbon monoxide and Vascular Diseases
| Article | Year |
|---|---|
The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.
Topics: Anemia, Sickle Cell; Animals; Carbon Monoxide; Clinical Trials as Topic; Disease Models, Animal; Hem | 2017 |
Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.
Topics: Animals; Carbon Monoxide; Humans; Hydrogen Sulfide; Models, Biological; Nitric Oxide; Scleroderma, S | 2018 |
Diffusing capacity.
Topics: Carbon Monoxide; Diffusion; Evaluation Studies as Topic; Humans; Lung; Lung Diseases, Interstitial; | 2009 |
Heme oxygenase: the key to renal function regulation.
Topics: Animals; Bilirubin; Blood Pressure; Carbon Monoxide; Diabetic Nephropathies; Enzyme Induction; Heme | 2009 |
Carbon monoxide in biology and microbiology: surprising roles for the "Detroit perfume".
Topics: Aldehyde Oxidoreductases; Anti-Infective Agents; Apoptosis; Bacterial Infections; Carbon Monoxide; H | 2009 |
Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target?
Topics: Adult; Aged; Bilirubin; Biomarkers; Carbon Monoxide; Child; Enterohepatic Circulation; Female; Glucu | 2011 |
Role of carbon monoxide in vascular diseases.
Topics: Animals; Blood Pressure; Brain; Carbon Monoxide; Heme Oxygenase (Decyclizing); Humans; Hypertension; | 2012 |
Regulation of ROS production and vascular function by carbon monoxide.
Topics: Animals; Blood Vessels; Carbon Monoxide; Humans; Neovascularization, Physiologic; Oxidation-Reductio | 2012 |
Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease.
Topics: Animals; Bilirubin; Carbon Monoxide; Humans; Lung Diseases; Oxidative Stress; Reperfusion Injury; Va | 2007 |
Carbon monoxide in sepsis.
Topics: Anti-Inflammatory Agents; Apoptosis; Carbon Monoxide; Dose-Response Relationship, Drug; Forecasting; | 2007 |
Carbon monoxide: medicinal chemistry and biological effects.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Graft Rejection; Graft Survival; Heart Transplan | 2007 |
Role of heme oxygenase-1 in vascular disease.
Topics: Animals; Atherosclerosis; Carbon Monoxide; Endothelium, Vascular; Enzyme Induction; Heme Oxygenase-1 | 2008 |
Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor.
Topics: Animals; Carbon Monoxide; Cytochrome P-450 Enzyme Inhibitors; Guanylate Cyclase; Humans; Muscle Rela | 1998 |
Carbon monoxide and vascular cell function (review).
Topics: Animals; Autocrine Communication; Blood Vessels; Carbon Monoxide; Heme; Humans; Muscle Tonus; Muscle | 1998 |
Carbon monoxide: its relationship to air pollution and cigarette smoking.
Topics: Air Pollution; Altitude; Arteriosclerosis; Binding Sites; Birth Weight; Carbon Monoxide; Carbon Mono | 1971 |
19 other studies available for carbon monoxide and Vascular Diseases
| Article | Year |
|---|---|
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients.
Topics: Biomarkers; Carbon Monoxide; Humans; Hypertension, Pulmonary; Pulmonary Fibrosis; Scleroderma, Syste | 2022 |
Anti-vinculin antibodies as a novel biomarker in Egyptian patients with systemic sclerosis.
Topics: Autoantibodies; Biomarkers; Carbon Monoxide; Egypt; Female; Humans; Lung Diseases, Interstitial; Mal | 2022 |
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
Topics: Carbon Monoxide; Cross-Sectional Studies; Humans; Hypertension, Pulmonary; Pulmonary Circulation; Va | 2022 |
Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement.
Topics: Biomarkers; Carbon Monoxide; Humans; Lung; MicroRNAs; Scleroderma, Diffuse; Scleroderma, Systemic; T | 2022 |
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
Topics: Aged; Carbon Monoxide; Female; Forced Expiratory Volume; Humans; Lung; Lung Diseases, Interstitial; | 2018 |
Carbon monoxide inhalation increases microparticles causing vascular and CNS dysfunction.
Topics: Animals; Carbon Monoxide; Central Nervous System Diseases; Inhalation Exposure; Mice; Mice, Inbred C | 2013 |
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Topics: Animals; Biomarkers; Carbon Monoxide; Ligands; Male; Matrix Metalloproteinases; Nanoparticles; Optic | 2017 |
Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Atherosclerosis; Carbon Monoxide; Car | 2009 |
Carbon monoxide--a toxic gas on the edge to clinical application.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbon Monoxide; Humans; Lung Diseases; Protective Agen | 2012 |
Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort.
Topics: Aged; Air Pollution; Biomarkers; Blood Coagulation Disorders; C-Reactive Protein; Carbon; Carbon Mon | 2012 |
Air pollution and autonomic and vascular dysfunction in patients with cardiovascular disease: interactions of systemic inflammation, overweight, and gender.
Topics: Aged; Air Pollutants; Air Pollution; Autonomic Nervous System Diseases; Blood Pressure Monitoring, A | 2012 |
[Cardio-vascular disorders of acute carbon monoxide intoxication; case of syphilitic aortitis, with sudden decompensation, of this origin].
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Heart; Humans; Syphilis, Cardiovascular; Vascular Diseas | 1951 |
The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting.
Topics: Animals; Arteriovenous Shunt, Surgical; Carbon Monoxide; Endothelium, Vascular; Heme Oxygenase (Decy | 2004 |
Carbon monoxide yield of cigarettes.
Topics: Carbon Monoxide; Humans; Ketotifen; Oxygen; Piperidines; Smoking; Tars; Thiophenes; Vascular Disease | 1980 |
Pulmonary vascular stress from carbon monoxide.
Topics: Animals; Capillaries; Carbon Monoxide; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Hydr | 1999 |
Ventilatory function in the Eisenmenger syndrome.
Topics: Adult; Carbon Monoxide; Eisenmenger Complex; Female; Humans; Lung; Lung Diseases; Lung Volume Measur | 1979 |
Diffusing capacity of the lung and nifedipine in systemic sclerosis.
Topics: Adult; Carbon Monoxide; Drug Administration Schedule; Female; Hemodynamics; Humans; Lung Diseases; M | 1990 |
Carbon monoxide in tobacco smoke and its influence on the development of vascular diseases.
Topics: Animals; Birth Weight; Carbon Monoxide; Female; Humans; Male; Pregnancy; Rabbits; Smoking; Vascular | 1972 |
The effect of short-term exposure to carbon monoxide on platelet stickiness.
Topics: Blood Cell Count; Carbon Monoxide; Glass; Hemoglobins; Platelet Adhesiveness; Smoking; Vascular Dise | 1971 |